Hepatobiliary Manifestations Following Two-Stages Elective Laparoscopic Restorative Proctocolectomy for Patients With Ulcerative Colitis. A Prospective Observational Study.
NCT ID: NCT05495178
Last Updated: 2022-10-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
167 participants
OBSERVATIONAL
2013-06-01
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis
NCT01798953
Post-Op Quality of Life After Colorectal Surgery
NCT00468455
Colorectal Cancer in Crohn's Disease
NCT04654494
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
NCT01604564
Comparison of Functional Outcomes Between Transanal and Laparoscopic vs Open Ileal Pouch-Anal Anastomosis
NCT04722757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hepatobiliary manifestations constitute one of the most common EIMs in IBD . Hepatobiliary manifestations are much more commonly associated with ulcerative colitis (UC) and include primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), fatty liver, cholelithiasis, primary biliary cholangitis, portal vein thrombosis, and hepatic abscess.
Most UC patients can be managed medically, but a minority requires proctocolectomy. Two-stage laparoscopic proctocolectomy (LPC) with ileal pouch-anal anastomosis (IPAA) is a cure for colitis, but its effect on hepatobiliary diseases is controversial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic restorative proctocolectomy
laparoscopic restorative proctocolectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* both sex diagnosed as ulcerative colitis with at least one hepatobiliary manifestation
* underwent laparoscopic restorative proctocolectomy with ileal pouch anal anastomosis
* with or without gallstones.
Exclusion Criteria
* alcohol abuse,
* pregnancy,
* severe heart failure or type II diabetes mellitus (defined as established diagnosis, HbA1c \> 6.4%, non-fasting glucose level \> 180 mg/dL, or on antidiabetic medication),
* development of complications or death related to the operation of LRP ,
* liver toxicity of IBD-related medications.,
* chronic viral hepatitis,
* haemochromatosis,
* Wilson's disease,
18 Years
69 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tamer.A.A.M.Habeeb
assistant professour of general and laparoscopic surgery
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
hepatobiliary manifestations
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.